Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant
According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
New annual observance aims to promote safe sun exposure, screening, and preventive healthcare as nearly 77% of Indians are estimated to be Vitamin D deficient
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
